ADCY10 and cancer: Many cancer therapeutics are designed to induce DNA damage or metaphase defects, which activate the DDR or SAC to trigger apoptotic cell death (e.g., cisplatin, doxorubicin, paclitaxel) under the premise that these checkpoints are independent [83,84].